[HTML][HTML] KDIGO 2021 clinical practice guideline for the management of glomerular diseases
BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
IGOKGD Work - Kidney international, 2021 - pubmed.ncbi.nlm.nih.gov
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases KDIGO
2021 Clinical Practice Guideline for the Management of Glomerular Diseases Kidney Int. 2021 …
2021 Clinical Practice Guideline for the Management of Glomerular Diseases Kidney Int. 2021 …
[引用][C] KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - iro.uiowa.edu
[引用][C] KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - cir.nii.ac.jp
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF][PDF] KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge… - 2021 - repository.ubn.ru.nl
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
[PDF][PDF] KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - hub.hku.hk
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge… - 2021 - research.rug.nl
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
[引用][C] KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.
Kidney International, 2021 - europepmc.org
A comment on this article appears in" Comments on the 2021 Kidney Disease: Improving
Global Outcomes (KDIGO) clinical practice guideline for anticoagulant therapy in patients …
Global Outcomes (KDIGO) clinical practice guideline for anticoagulant therapy in patients …
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
IGOKGD Work - Kidney international, 2021 - pubmed.ncbi.nlm.nih.gov
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases KDIGO
2021 Clinical Practice Guideline for the Management of Glomerular Diseases Kidney Int. 2021 …
2021 Clinical Practice Guideline for the Management of Glomerular Diseases Kidney Int. 2021 …